REQUEST A DEMO
Total
USD $0.00
Search more companies

Biotecno Zf Sas (Colombia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Biotecno Zf Sas Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Biotecno Zf Sas is a company based in Colombia, with its head office in Tocancipa. The enterprise operates in the Pharmaceutical Preparation Manufacturing industry. Biotecno Zf Sas was incorporated on November 05, 2015. Biotecno Zf Sas currently employs 23 (2024) people. In 2023, the company reported a net sales revenue increase of 31.89%. A growth of 6.09% was recorded in its total assets. The net profit margin of Biotecno Zf Sas increased by 11.99% in 2023.

Headquarters
Vrd Tibito Zf Tocancipa Km 1 5 Briceno Zipaquira Bg 13 A Mz 3
Tocancipa; Cundinamarca;

Contact Details: Purchase the Biotecno Zf Sas report to view the information.

Basic Information
Total Employees:
Purchase the Biotecno Zf Sas report to view the information.
Outstanding Shares:
Purchase the Biotecno Zf Sas report to view the information.
Incorporation Date:
November 05, 2015
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Purchase this report to view the information.
Fiscal Inspector
Company Performance
Financial values in the chart are available after Biotecno Zf Sas report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
31.89%
Total operating revenue
47.38%
Operating profit (EBIT)
114.33%
EBITDA
103.62%
Net Profit (Loss) for the Period
198%
Total assets
6.09%
Total equity
76.05%
Operating Profit Margin (ROS)
10.72%
Net Profit Margin
11.99%
Return on Equity (ROE)
26.6%
Debt to Equity Ratio
-24.25%
Quick Ratio
0.53%
Cash Ratio
0.03%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?